Halley Gilbert

Board Member

Ms Gilbert joined the Arcutis board in May 2020. She brings more than 20 years of experience in legal, corporate and business development, compliance, and government affairs. Ms Gilbert is currently chief legal officer and chief operating officer of Tubulis, where she oversees legal and administrative functions and helps shape corporate strategy and U.S. expansion at a pivotal stage of clinical and corporate growth.

Most recently, Ms Gilbert served as chief legal officer of Cargo Therapeutics, where she played a key leadership role in the company’s initial public offering and subsequent sale. Prior to Cargo, she served as chief legal officer at NeoGenomics, Inc., a premier cancer diagnostics, pharma services, and informatics company. Earlier, she was the first employee and chief operating officer at Adagio Therapeutics (now Invivyd, Inc.). She helped scale the company from launch through IPO and supported its transition from early R&D to late-stage clinical development.

Previously, Ms Gilbert spent 12 years in roles of increasing scope at Ironwood Pharmaceuticals, Inc., including senior vice president of corporate development and chief dministrative officer, where she oversaw corporate and business development, legal, compliance, and government affairs, and as senior vice president, chief legal officer, and corporate secretary. Before Ironwood, she was vice president, deputy general counsel at Cubist Pharmaceuticals, Inc., and earlier served as corporate counsel at Genzyme Corp., prior to its acquisition by Sanofi. She began her career at Skadden, Arps, Slate, Meagher & Flom LLP, specializing in mergers and acquisitions and securities law.

Ms Gilbert currently serves on the boards of directors of CytomX TherapeuticsandVaxcyte, Inc. (in addition to Arcutis). Previous board roles included Dermira, Inc., prior to its acquisition by Eli Lilly and Company, and Achaogen, Inc.

Ms Gilbert holds a BA from Tufts University and a JD from Northwestern University School of Law.